JT
SRPT icon

Jupiter Topco’s Sarepta Therapeutics SRPT Stock Holding History

Jupiter Topco’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Buy
+46,265
New +$875K ﹤0.01% 1870

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's SRPT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 46,265 shares worth $831K. The stake represents ﹤0.01% of the portfolio and ranks #1870 among its holdings.

298 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Jupiter Topco held 46,265 shares of Sarepta Therapeutics worth $831K as of Q2 2026.
  • Sarepta Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1870 holding.
  • 298 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.